针对痴呆症患者家庭照护者的互联网自助式 "接纳与承诺疗法"(iACT4CARERS)的临床和成本效益:针对不同种族家庭照护者的随机对照试验研究方案

IF 2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Naoko Kishita , Rebecca L. Gould , Lance M. McCracken , Mizanur Khondoker , David A. Turner , Polly-Anna Ashford , Emma Flanagan , Barbara Czyznikowska , Erica Richmond , Megan Riggey , Ana Paula Trucco , Matthew Hammond , Aditya Nautiyal , Morag Farquhar
{"title":"针对痴呆症患者家庭照护者的互联网自助式 \"接纳与承诺疗法\"(iACT4CARERS)的临床和成本效益:针对不同种族家庭照护者的随机对照试验研究方案","authors":"Naoko Kishita ,&nbsp;Rebecca L. Gould ,&nbsp;Lance M. McCracken ,&nbsp;Mizanur Khondoker ,&nbsp;David A. Turner ,&nbsp;Polly-Anna Ashford ,&nbsp;Emma Flanagan ,&nbsp;Barbara Czyznikowska ,&nbsp;Erica Richmond ,&nbsp;Megan Riggey ,&nbsp;Ana Paula Trucco ,&nbsp;Matthew Hammond ,&nbsp;Aditya Nautiyal ,&nbsp;Morag Farquhar","doi":"10.1016/j.cct.2024.107685","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Following the successful completion of feasibility and acceptability studies of internet-delivered self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS), a full-scale randomised controlled trial (RCT) evaluating its clinical and cost effectiveness will be conducted. This paper describes the design and protocol for a multi-site, parallel, single-blind, 2-arm RCT evaluating the clinical and cost effectiveness of iACT4CARERS plus treatment-as-usual (TAU) in comparison to TAU alone for reducing anxiety in family carers of people with dementia.</p></div><div><h3>Methods</h3><p>496 family carers aged ≥18 years, who are caring for a person with dementia, will be recruited from national healthcare services, general practices and community groups in England. Participants randomised to the intervention arm will receive iACT4CARERS over 12 weeks. Participants will complete outcome measures at baseline (0 weeks) and at 12-weeks and 24-weeks post-randomisation. The primary outcome and timepoint will be anxiety at 12 weeks. Secondary outcomes will include psychological flexibility, depression, and cost-effectiveness (cost per quality adjusted life years). Primary analyses will be by intention-to-treat and data will be analysed using linear mixed models. Fidelity and quality of implementation will be assessed and contextual factors associated with variation in outcomes identified in a process evaluation.</p></div><div><h3>Conclusion</h3><p>If iACT4CARERS is found to be effective and affordable, this self-help intervention, including minimal contact with minimally trained therapists, has the potential to be rolled out widely within healthcare services in the UK, reducing inequality in access to psychological services among this population.</p><p>Clinical trials registration: ISRCTN registry identifier ISRCTN45995725.</p></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"146 ","pages":"Article 107685"},"PeriodicalIF":2.0000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1551714424002684/pdfft?md5=0a9b753137f736d6325f012e66a2cfb6&pid=1-s2.0-S1551714424002684-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The clinical and cost effectiveness of internet-delivered self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): Study protocol for a randomised controlled trial with ethnically diverse family carers\",\"authors\":\"Naoko Kishita ,&nbsp;Rebecca L. Gould ,&nbsp;Lance M. McCracken ,&nbsp;Mizanur Khondoker ,&nbsp;David A. Turner ,&nbsp;Polly-Anna Ashford ,&nbsp;Emma Flanagan ,&nbsp;Barbara Czyznikowska ,&nbsp;Erica Richmond ,&nbsp;Megan Riggey ,&nbsp;Ana Paula Trucco ,&nbsp;Matthew Hammond ,&nbsp;Aditya Nautiyal ,&nbsp;Morag Farquhar\",\"doi\":\"10.1016/j.cct.2024.107685\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Following the successful completion of feasibility and acceptability studies of internet-delivered self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS), a full-scale randomised controlled trial (RCT) evaluating its clinical and cost effectiveness will be conducted. This paper describes the design and protocol for a multi-site, parallel, single-blind, 2-arm RCT evaluating the clinical and cost effectiveness of iACT4CARERS plus treatment-as-usual (TAU) in comparison to TAU alone for reducing anxiety in family carers of people with dementia.</p></div><div><h3>Methods</h3><p>496 family carers aged ≥18 years, who are caring for a person with dementia, will be recruited from national healthcare services, general practices and community groups in England. Participants randomised to the intervention arm will receive iACT4CARERS over 12 weeks. Participants will complete outcome measures at baseline (0 weeks) and at 12-weeks and 24-weeks post-randomisation. The primary outcome and timepoint will be anxiety at 12 weeks. Secondary outcomes will include psychological flexibility, depression, and cost-effectiveness (cost per quality adjusted life years). Primary analyses will be by intention-to-treat and data will be analysed using linear mixed models. Fidelity and quality of implementation will be assessed and contextual factors associated with variation in outcomes identified in a process evaluation.</p></div><div><h3>Conclusion</h3><p>If iACT4CARERS is found to be effective and affordable, this self-help intervention, including minimal contact with minimally trained therapists, has the potential to be rolled out widely within healthcare services in the UK, reducing inequality in access to psychological services among this population.</p><p>Clinical trials registration: ISRCTN registry identifier ISRCTN45995725.</p></div>\",\"PeriodicalId\":10636,\"journal\":{\"name\":\"Contemporary clinical trials\",\"volume\":\"146 \",\"pages\":\"Article 107685\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1551714424002684/pdfft?md5=0a9b753137f736d6325f012e66a2cfb6&pid=1-s2.0-S1551714424002684-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary clinical trials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551714424002684\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714424002684","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景在成功完成针对痴呆症患者家庭照顾者的互联网自助式接受与承诺疗法(iACT4CARERS)的可行性和可接受性研究后,将开展一项全面的随机对照试验(RCT)来评估其临床和成本效益。本文介绍了一项多地点、平行、单盲、双臂随机对照试验的设计和方案,该试验将评估 iACT4CARERS 加上 "常规治疗"(TAU)与单独使用 "常规治疗"(TAU)在减轻痴呆症患者家庭照护者焦虑方面的临床和成本效益。被随机分配到干预组的参与者将接受为期 12 周的 iACT4CARERS 治疗。参与者将在基线(0 周)、随机后 12 周和 24 周时完成结果测量。主要结果和时间点将是 12 周时的焦虑。次要结果包括心理灵活性、抑郁和成本效益(每质量调整生命年的成本)。主要分析将采用意向治疗法,并使用线性混合模型对数据进行分析。结论如果发现 iACT4CARERS 是有效且可负担得起的,那么这种自助式干预(包括与训练有素的治疗师进行最少的接触)就有可能在英国的医疗保健服务机构中广泛推广,从而减少这类人群在获得心理服务方面的不平等:临床试验注册:ISRCTN 注册标识符 ISRCTN45995725。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The clinical and cost effectiveness of internet-delivered self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS): Study protocol for a randomised controlled trial with ethnically diverse family carers

Background

Following the successful completion of feasibility and acceptability studies of internet-delivered self-help Acceptance and Commitment Therapy for family carers of people with dementia (iACT4CARERS), a full-scale randomised controlled trial (RCT) evaluating its clinical and cost effectiveness will be conducted. This paper describes the design and protocol for a multi-site, parallel, single-blind, 2-arm RCT evaluating the clinical and cost effectiveness of iACT4CARERS plus treatment-as-usual (TAU) in comparison to TAU alone for reducing anxiety in family carers of people with dementia.

Methods

496 family carers aged ≥18 years, who are caring for a person with dementia, will be recruited from national healthcare services, general practices and community groups in England. Participants randomised to the intervention arm will receive iACT4CARERS over 12 weeks. Participants will complete outcome measures at baseline (0 weeks) and at 12-weeks and 24-weeks post-randomisation. The primary outcome and timepoint will be anxiety at 12 weeks. Secondary outcomes will include psychological flexibility, depression, and cost-effectiveness (cost per quality adjusted life years). Primary analyses will be by intention-to-treat and data will be analysed using linear mixed models. Fidelity and quality of implementation will be assessed and contextual factors associated with variation in outcomes identified in a process evaluation.

Conclusion

If iACT4CARERS is found to be effective and affordable, this self-help intervention, including minimal contact with minimally trained therapists, has the potential to be rolled out widely within healthcare services in the UK, reducing inequality in access to psychological services among this population.

Clinical trials registration: ISRCTN registry identifier ISRCTN45995725.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
4.50%
发文量
281
审稿时长
44 days
期刊介绍: Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信